SCHEMBL8473238

SCHEMBL8473238

Cn1cc(CN2CCNCC2)c2ccccc21

nearest known ligand 0.66

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.66
GLA P06280 1/20 0.66
ALDH1A1 P00352 2/20 0.60
TSHR P16473 1/20 0.60
HTR6 P50406 4/20 0.59
SLC6A4 P31645 1/20 0.56
GPR84 Q9NQS5 1/20 0.56
DRD2 P14416 1/20 0.55
DRD4 P21917 1/20 0.55
DRD3 P35462 1/20 0.55
HDAC8 Q9BY41 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
HTR2A P28223 1/20 0.50
SIGMAR1 Q99720 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
DOCK5 Q9H7D0 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5961922 0.84 LMNA (0.69) LMNAGLAALDH1A1TSHRHTR6
SCHEMBL14375226 0.81 LMNA (0.64) LMNAGLAALDH1A1TSHRSLC6A4
SCHEMBL2162689 0.79 LMNA (1.00) LMNAGLAALDH1A1TSHRGPR84
Hydrochloric Acid SCHEMBL28233643 0.77 HTR7 (0.60) LMNAGLAHTR6
Hydrochloric Acid SCHEMBL28233646 0.77 HTR7 (0.61) LMNAHTR6
SCHEMBL28780669 0.76 SLC6A4 (0.75) LMNAGLAALDH1A1TSHRSLC6A4
SCHEMBL5196972 0.75 LMNA (0.81) LMNAGLAALDH1A1TSHRHTR6
SCHEMBL947747 0.74 HTR6 (1.00) HTR6
SCHEMBL15084330 0.73 LMNA (0.55) LMNAGLAALDH1A1TSHRGPR84
SCHEMBL5881100 0.73 GPR84 (1.00) LMNAGLAALDH1A1TSHRSLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5889032-A Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them DR. REDDY'S RESEARCH FOUNDATION (IN) 1999-03-30 US disclosed